Arch Therapeutics, Inc.

ARTH · OTC
Analyze with AI
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Activities
Net Income-$7-$5-$6-$5
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$1
Change in WC$2$1-$0-$1
Other Non-Cash$1-$0-$0-$1
Operating Cash Flow-$3-$4-$6-$5
Investing Activities
PP&E Inv.-$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0-$0-$0
Financing Activities
Debt Repay.$1$3$1$1
Stock Issued$2$0$6$2
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0$0$1
Financing Cash Flow$3$3$7$4
Forex Effect$0$0$0$0
Net Chg. in Cash-$1-$2$1-$1
Supplemental Information
Beg. Cash$1$2$1$2
End Cash$0$1$2$1
Free Cash Flow-$3-$4-$6-$5
Arch Therapeutics, Inc. (ARTH) Financial Statements & Key Stats | AlphaPilot